Frank Reed

Q1 data reveals a cooling market, offering businesses a rare opportunity while challenging insurers to adapt. Here’s what the shift means for you.

A novel alpha-radiation therapy, Alpha DaRT, begins European trials, offering a new path for pancreatic cancer patients with no other treatment options.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.

Football legend Luis Figo is the new face of TenTrade, but the deal highlights growing scrutiny over celebrity endorsements of high-risk finance.

An essay contest for medical trainees aims to fix a critical gap in patient care, using frontline stories to reshape how doctors learn about nutrition.

With over 47,000 members, Astiva Health's culturally tailored Medicare plans are outpacing rivals. Now, it's pivoting toward sustainable profit.

How the Netherlands' largest energy provider migrated 1,000+ agents to the cloud, slashing tech costs by 50% and transforming employee satisfaction.

Belk renews its partnership with Craig Conover's Sewing Down South, a move that highlights the power of celebrity brands and a deep Southern retail strategy.

As it hits 100 properties, Banyan Group unveils a new strategy to prove that global growth and genuine environmental stewardship can go hand-in-hand.

With new sales and customer success chiefs who are former colleagues of the CEO, LearningSpring aims to dominate the school choice management market.

With a $1M grant from Wells Fargo, five specialists will tackle financial exclusion in major US cities, building on a model that has already helped millions.

Astellas and Pfizer's PADCEV-Keytruda combo, showing a 47% drop in recurrence risk, earns FDA Priority Review, offering new hope for bladder cancer patients.

Interim trial data shows IPH5201 plus durvalumab yields pathological complete response rates up to 50%, far surpassing current standards for resectable NSCLC.

Six years after Hurricane Laura, Lake Charles opens a world-class Mardi Gras museum, signaling a new era of cultural tourism and resilience.

Rove launches three new potent pre-roll strains for 4/20, tapping into a booming market where infused products and high-potency cannabis now dominate.

Preliminary Q1 data from Auna shows rising demand for specialized care in Peru, Colombia, and Mexico, offering investors a transparent new look.

The aviation finance giant taps new capital pools with a dual-tranche facility, part of a $2.5B haul signaling aggressive growth and market confidence.

The new CMS Medicare App Library is giving millions of seniors access to AI-driven health tools, but can technology bridge the gap in patient care?

ETP adds four top experts from academia and industry to its advisory board, signaling a major push for practical, enforceable AI governance frameworks.

Robbyant's new open-source AI model achieves a 2.8x accuracy leap in 3D mapping, poised to transform robotics, autonomous driving, and AR.